| Glioblastoma multiforme: Pathogenesis and treatment C Alifieris, DT Trafalis Pharmacology & therapeutics 152, 63-82, 2015 | 923 | 2015 |
| Targeting Programmed Cell Death -1 (PD-1) and Ligand (PD-L1): A new era in cancer active immunotherapy. TDT Constantinidou A, Alifieris C Pharmacol Ther 194, 84-106., 2019 | 328 | 2019 |
| Saffron as a source of novel acetylcholinesterase inhibitors: molecular docking and in vitro enzymatic studies GD Geromichalos, FN Lamari, MA Papandreou, DT Trafalis, M Margarity, ... Journal of agricultural and food chemistry 60 (24), 6131-6138, 2012 | 202 | 2012 |
| Treatment of colorectal cancer with and without bevacizumab: a phase III study GP Stathopoulos, C Batziou, D Trafalis, J Koutantos, S Batzios, ... Oncology 78 (5-6), 376-381, 2010 | 153 | 2010 |
| The role of isothiocyanates as cancer chemo-preventive, chemo-therapeutic and anti-melanoma agents M Mitsiogianni, G Koutsidis, N Mavroudis, DT Trafalis, S Botaitis, R Franco, ... Antioxidants 8 (4), 106, 2019 | 131 | 2019 |
| CYP2E1 and risk of chemically mediated cancers DT Trafalis, ES Panteli, A Grivas, C Tsigris, PN Karamanakos Expert opinion on drug metabolism & toxicology 6 (3), 307-319, 2010 | 81 | 2010 |
| Synthesis and anticancer activity of novel 3, 6-disubstituted 1, 2, 4-triazolo-[3, 4-b]-1, 3, 4-thiadiazole derivatives G Charitos, DT Trafalis, P Dalezis, C Potamitis, V Sarli, P Zoumpoulakis, ... Arabian Journal of Chemistry 12 (8), 4784-4794, 2019 | 70 | 2019 |
| Synthesis and biological evaluation of a Platinum (II)-c (RGDyK) conjugate for integrin-targeted photodynamic therapy T Chatzisideri, S Thysiadis, S Katsamakas, P Dalezis, I Sigala, ... European Journal of Medicinal Chemistry 141, 221-231, 2017 | 57 | 2017 |
| Clonal chromosome rearrangements in hairy cell leukemia: personal experience and review of literature C Sambani, DTP Trafalis, C Mitsoulis-Mentzikoff, E Poulakidas, ... Cancer genetics and cytogenetics 129 (2), 138-144, 2001 | 52 | 2001 |
| Stauffer's syndrome variant associated with renal cell carcinoma G Giannakos, X Papanicolaou, D Trafalis, I Michaelidis, G Margaritis, ... International journal of urology 12 (8), 757-759, 2005 | 50 | 2005 |
| Overview on the current status of virtual high-throughput screening and combinatorial chemistry approaches in multi-target anticancer drug discovery; Part I GD Geromichalos, CE Alifieris, EG Geromichalou, DT Trafalis J buon 21 (4), 764-79, 2016 | 49 | 2016 |
| Pressure dressing in breast surgery: is this the solution for seroma formation? M Kontos, A Petrou, E Prassas, C Tsigris, P Roy, D Trafalis, E Bastounis, ... Journal of BU ON.: Official Journal of the Balkan Union of Oncology 13 (1 …, 2008 | 46 | 2008 |
| Lactandrate: a D-homo-aza-androsterone alkylator in the treatment of breast cancer DTP Trafalis, GD Geromichalos, C Koukoulitsa, A Papageorgiou, ... Breast cancer research and treatment 97, 17-31, 2006 | 44 | 2006 |
| Evidence for efficacy of treatment with the anti-PD-1 mab nivolumab in radiation and multichemorefractory advanced penile squamous cell carcinoma DT Trafalis, CE Alifieris, A Kalantzis, KE Verigos, C Vergadis, S Sauvage Journal of Immunotherapy 41 (6), 300-305, 2018 | 43 | 2018 |
| Hybrid aza-steroid alkylators in the treatment of colon cancer DTP Trafalis Cancer letters 243 (2), 202-210, 2006 | 40 | 2006 |
| Sulforaphane and iberin are potent epigenetic modulators of histone acetylation and methylation in malignant melanoma M Mitsiogianni, DT Trafalis, R Franco, V Zoumpourlis, A Pappa, ... European Journal of Nutrition 60, 147-158, 2021 | 39 | 2021 |
| How far are we from prescribing fasting as anticancer medicine? MV Deligiorgi, C Liapi, DT Trafalis International Journal of Molecular Sciences 21 (23), 9175, 2020 | 36 | 2020 |
| Allyl isothiocyanate regulates lysine acetylation and methylation marks in an experimental model of malignant melanoma M Mitsiogianni, T Mantso, DT Trafalis, HP Vasantha Rupasinghe, ... European journal of nutrition 59, 557-569, 2020 | 33 | 2020 |
| Harnessing the versatile role of OPG in bone oncology: counterbalancing RANKL and TRAIL signaling and beyond MV Deligiorgi, MI Panayiotidis, J Griniatsos, DT Trafalis Clinical & experimental metastasis 37 (1), 13-30, 2020 | 33 | 2020 |
| Phase II study of bevacizumab plus irinotecan on the treatment of relapsed resistant small cell lung cancer DT Trafalis, C Alifieris, GP Stathopoulos, N Sitaras Cancer chemotherapy and pharmacology 77, 713-722, 2016 | 32 | 2016 |
Constantinos E. AlifierisIcahn School of Medicine at Mount SinaiVerified email at mountsinai.org
